abstract |
A deuterium-enriched 2,4-thiazolidinedione compound and a pharmaceutical composition containing the deuterium-enriched compound are provided. 5-Deuterium-enriched 2,4-thiazolidinedione (eg, 5- [4- [2- (5-ethyl-2-pyridyl) -2-oxoethoxy] benzyl] -5-deutero-thiazolidine) -2,4-dione), its deuterated derivatives, its stereoisomers, its pharmaceutically acceptable salt forms and therapies using them. [Selection figure] None |